Chlorpromazine binding to Na+, K+-ATPase and photolabeling: involvement of the ouabain site monitored by fluorescence.
This work reports the results of ultraviolet irradiation on the interaction of the phototoxic antipsychotic drug chlorpromazine (CPZ) with the sodium pump Na+, K+-ATPase. The study was performed by monitoring the fluorescence modifications of CPZ itself and of the specific probe anthroylouabain (AO). CPZ association with Na+, K+-ATPase was found to modify the kinetics of CPZ-photodegradation. It was demonstrated that UV irradiation produces a stable fluorescent photoproduct of CPZ covalently bound to Na+, K+-ATPase. The fluorescent probe AO, which specifically binds to the extracellular ouabain site of the pump, was used to localize the CPZ binding site. UV-irradiation of AO-labeled Na+, K+-ATPase treated with CPZ at concentration about 20 microM produced dose-dependent modifications of the AO fluorescence, e.g. increased quantum yield and blue shift. The results demonstrated that CPZ binds near the ouabain site. The photo-induced reaction of CPZ with AO-labeled Na+, K+-ATPase protected the ouabain site from the aqueous environment. It was also found that UV irradiation of CPZ-treated enzyme obstructs the binding of AO, which suggested occlusion of the ouabain site. This effect can be evaluated for a potential use of CPZ in photochemotherapy.
Guevara
Elmer A C
EA
Department of Physics, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, Brazil.
de Lourdes Barriviera
Maria
M
Hassón-Voloch
Aída
A
Louro
Sonia R W
SR
D014150:Antipsychotic Agents / Q000378:metabolism*; D001665:Binding Sites; D002746:Chlorpromazine / Q000378:metabolism*; D010042:Ouabain / Q000378:metabolism*; D010777:Photochemistry; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013050:Spectrometry, Fluorescence
D014150:Antipsychotic Agents; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase; D002746:Chlorpromazine